Immune Checkpoint Inhibitors for Hepatobiliary Cancers

Review an on-demand Webcast from a live Webinar focused on current best practices and emerging strategies in using immune checkpoint inhibitors to treat patients with hepatocellular carcinoma and biliary tract cancers and then download the slides and read an associated expert commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca